BridgeBio have demonstrably improved its development of an new solution for amyloid heart disease, utilizing Attruby. Preliminary clinical results indicates significant benefits for individuals affected by a https://biotech041370.tinyblogging.com/company-progresses-cardiac-amyloidosis-management-through-attruby-86374895